These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
142 related articles for article (PubMed ID: 883333)
21. Sixteen years follow-up results of a randomized phase II trial of neoadjuvant fluorouracil, doxorubicin, and cyclophosphamide (FAC) compared with cyclophosphamide, methotrexate, and 5-fluorouracil (CMF) in stage III breast cancer: GOCS experience. Leone JP; Leone J; Vallejo CT; Pérez JE; Romero AO; Machiavelli MR; Romero Acuña L; Domínguez ME; Langui M; Fasce HM; Leone BA; Ortiz E; Iturbe J; Zwenger AO Breast Cancer Res Treat; 2014 Jan; 143(2):313-23. PubMed ID: 24327333 [TBL] [Abstract][Full Text] [Related]
22. Letter: Chemotherapy after mastectomy. Cavalli F; Alberto P; Jungi F; Martz G Lancet; 1976 May; 1(7970):1185. PubMed ID: 58229 [No Abstract] [Full Text] [Related]
23. Sequential methotrexate and fluorouracil for the treatment of node-negative breast cancer patients with estrogen receptor-negative tumors: eight-year results from National Surgical Adjuvant Breast and Bowel Project (NSABP) B-13 and first report of findings from NSABP B-19 comparing methotrexate and fluorouracil with conventional cyclophosphamide, methotrexate, and fluorouracil. Fisher B; Dignam J; Mamounas EP; Costantino JP; Wickerham DL; Redmond C; Wolmark N; Dimitrov NV; Bowman DM; Glass AG; Atkins JN; Abramson N; Sutherland CM; Aron BS; Margolese RG J Clin Oncol; 1996 Jul; 14(7):1982-92. PubMed ID: 8683228 [TBL] [Abstract][Full Text] [Related]
24. Evidence of a castration-mediated effect of adjuvant cytotoxic chemotherapy in premenopausal breast cancer. Brincker H; Rose C; Rank F; Mouridsen HT; Jakobsen A; Dombernowsky P; Panduro J; Andersen KW J Clin Oncol; 1987 Nov; 5(11):1771-8. PubMed ID: 3316514 [TBL] [Abstract][Full Text] [Related]
25. Adjuvant treatment of cancer. II. Breast carcinoma. Viola MV; Nystrom JS Conn Med; 1977 Jun; 41(6):333-5. PubMed ID: 872584 [No Abstract] [Full Text] [Related]
26. Doxorubicin and cyclophosphamide versus cyclophosphamide, methotrexate, and 5-fluorouracil as adjuvant chemotherapy in breast cancer. Livi L; Saieva C; Borghesi S; De Luca Cardillo C; Scotti V; Mangoni M; Greto D; Cataliotti L; Paiar F; Bianchi S; Biti GP J Chemother; 2009 Nov; 21(5):558-65. PubMed ID: 19933048 [TBL] [Abstract][Full Text] [Related]
27. Benefits of axillary radiotherapy unclear in women with early stage breast cancer undergoing conservative breast surgery without axillary dissection. Sanuki-Fujimoto N Cancer Treat Rev; 2005 Oct; 31(6):496-500. PubMed ID: 16199127 [No Abstract] [Full Text] [Related]
28. [Chemotherapy of inoperable breast cancer with a combination of 5-fluorouracil, methotrexate, vincristine, cyclophosphamide and prednisolone]. Raevskiĭ IG Sov Med; 1976 Aug; (8):112-4. PubMed ID: 1006408 [No Abstract] [Full Text] [Related]
29. [Drug resistance and hormone dependence of a case of breast cancer]. Di Pietro S; Rovini D Tumori; 1975; 61(6):581-3. PubMed ID: 178081 [TBL] [Abstract][Full Text] [Related]
30. A randomized trial of postoperative five-versus three-drug chemotherapy after mastectomy: a Cancer and Leukemia Group B (CALGB) study. Weiss RB; Tormey DC; Holland F; Weinberg VE; Lesnick G; Perloff M; Falkson G; Glidewell OJ Recent Results Cancer Res; 1982; 80():170-6. PubMed ID: 7036280 [TBL] [Abstract][Full Text] [Related]
31. Combination chemotherapy as an adjuvant treatment in operable breast cancer. Bonadonna G; Brusamolino E; Valagussa P; Rossi A; Brugnatelli L; Brambilla C; De Lena M; Tancini G; Bajetta E; Musumeci R; Veronesi U N Engl J Med; 1976 Feb; 294(8):405-10. PubMed ID: 1246307 [TBL] [Abstract][Full Text] [Related]
32. United States trials of adjuvant therapy. Fisher B World J Surg; 1977 May; 1(3):331-5. PubMed ID: 407729 [No Abstract] [Full Text] [Related]
33. Multimodal therapy with CMF in resectable breast cancer with positive axillary nodes: the Milan Institute experience. Bonadonna G; Valagussa P; Rossi A; Tancini G; Brambilla C; Marchini S; Veronesi U Recent Results Cancer Res; 1982; 80():149-56. PubMed ID: 7036277 [No Abstract] [Full Text] [Related]
34. [Chemotherapy as an adjuvant treatment in breast cancer (author's transl)]. Firusian N; Hossfeld DK; John V Rontgenblatter; 1978 Jul; 31(7):423-8. PubMed ID: 99800 [TBL] [Abstract][Full Text] [Related]
35. [Encouraging results with cytostatic therapy in metastasizing breast cancer (author's transl)]. Michlmayr G; Kratzer H; Denz H; Huber H Wien Klin Wochenschr; 1981 Mar; 93(6):205-7. PubMed ID: 7281697 [TBL] [Abstract][Full Text] [Related]
36. Dose-response effect of adjuvant chemotherapy in breast cancer. Bonadonna G; Valagussa P N Engl J Med; 1981 Jan; 304(1):10-5. PubMed ID: 7432433 [TBL] [Abstract][Full Text] [Related]
37. Quality of adjuvant CMF chemotherapy for node-positive primary breast cancer: a population-based study. Schaapveld M; de Vries EG; van der Graaf WT; Otter R; Willemse PH J Cancer Res Clin Oncol; 2004 Oct; 130(10):581-90. PubMed ID: 15258754 [TBL] [Abstract][Full Text] [Related]
38. Comparison of adjuvant chemotherapy with methotrexate and fluorouracil with and without cyclophosphamide in breast cancer patients with one to three positive axillary lymph nodes. Shapiro CL; Gelman RS; Hayes DF; Osteen R; Obando A; Canellos GP; Frei E; Henderson IC J Natl Cancer Inst; 1993 May; 85(10):812-7. PubMed ID: 8487326 [TBL] [Abstract][Full Text] [Related]
39. Combination chemotherapy for disseminated carcinoma of the breast. Lozada JA; Grillo-López A; Vélez-Garciá E Bol Asoc Med P R; 1975 Jun; 67(6):157-63. PubMed ID: 1055588 [No Abstract] [Full Text] [Related]
40. [Combined irradiation and chemotherapy as postoperative treatment of breast cancer]. von der Maase H; Sveinsson T Ugeskr Laeger; 1978 Jul; 140(28):1676-8. PubMed ID: 695028 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]